Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Doc groups say payer promises not enough to address care denials
MGMA and others who are part of the “Regulatory Relief Coalition” are urging Congress to continue pushing forward with the Improving Seniors’ Timely Access to Care Act.
Russian researcher strategizes on collaboration with China over healthcare AI
Have you ever wondered what China and Russia would talk about if they were to discuss AI in healthcare? It turns out they do just that—and a newly published academic paper straight out of the Russian Federation offers a glimpse into the dialogue.
10-second brain MRI scans possible with newly FDA-cleared deep learning reconstruction software
The artificial intelligence-enabled software offers accelerated acquisition times, improved image resolution and one-click workflows for technologists.
'Technical issue' prevents providers from receiving alerts on actionable imaging findings for 3 years
The system uses color coded flags to alert general practitioners that a patient's imaging report contains "serious or unexpected” findings.
FDA shares warning after Johnson & Johnson heart pump controllers linked to 3 deaths
Johnson & Johnson MedTech has received reports of its Automated Impella Controller failing to connect properly with Impella heart pumps. If this happens, the FDA warned, it may put patients at risk.

Radiology society says EPA proposal could pose ‘significant disruptions’ to patient care

New standards for disinfecting devices could reduce sterilization capacity by upward of 50%, advocates estimate.

American Medical Association slams Supreme Court ruling on affirmative action, saying it 'undermines decades of progress'

"Diversity is vital to healthcare, and this court ruling deals a serious blow to our goal of increasing medical career opportunities for historically marginalized and minoritized people."

Cardiologists, radiologists say EPA’s new sterilization proposal could put patients at risk

The primary concern is that sterilization facilities and healthcare providers would not have enough time to adapt to the proposal. Devices impacted would include pacemakers, angioplasty balloons and catheters, just to name a few.

Donislecel Lantidra FDA type 1 diabetes severe hypoglycemia

FDA approves first cellular therapy to treat type 1 diabetes

The new therapy, made from the pancreatic cells of deceased donors, is designed to help adult type 1 diabetes with severe hypoglycemia go a year or longer without needing to take insulin.

Former Johnson & Johnson sales rep indicted for defrauding hospital out of hundreds of thousands of dollars

The sales representative is alleged to have falsely documented his sales numbers on invoices submitted to the hospital’s billing department in addition to interfering with their sterilization processes, according to the DOJ.

FDA announces recall of more than 250,000 interventional devices due to risk of catheter separation

The FDA has said this is a Class I recall, which means using the devices “may cause serious injuries or death.” A total of 18 injuries have been reported so far.

FDA approves Bayer’s imaging agent Ultravist for use in contrast-enhanced mammography

The Germany-based corporation said this is the “only contrast agent approved for this indication” in America.

American College of Radiology voices support for MD tapped to lead NIH amid confirmation hearing holdup

“We must not lose momentum," ACR, the Academy for Radiology & Biomedical Imaging Research and more than 100 other organizations wrote to leaders of the U.S. Senate.

Policy & Regulations

Doc groups say payer promises not enough to address care denials

Russian researcher strategizes on collaboration with China over healthcare AI

10-second brain MRI scans possible with newly FDA-cleared deep learning reconstruction software

'Technical issue' prevents providers from receiving alerts on actionable imaging findings for 3 years

FDA shares warning after Johnson & Johnson heart pump controllers linked to 3 deaths